23 Feb Aspect Biosystems
Eric Roos, Chief Business Development Officer
Oct. 14 | 11:00am | BlueRock Therapeutics Ballroom
Aspect Biosystems is a biotechnology company creating bioprinted therapeutics as medicines of the future. Aspect is applying its microfluidic 3D bioprinting technology internally to develop these advanced cell therapies, and partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.